G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $226,000 | -0.4% | 18,100 | -39.5% | 0.00% | 0.0% |
Q1 2022 | $227,000 | -74.8% | 29,910 | -66.1% | 0.00% | -83.3% |
Q4 2021 | $902,000 | +34.4% | 88,330 | +76.6% | 0.02% | +100.0% |
Q3 2021 | $671,000 | -39.6% | 50,020 | +8.3% | 0.01% | -36.8% |
Q1 2021 | $1,111,000 | – | 46,180 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 120,000 | $172,800 | 0.15% |
DENALI ADVISORS LLC | 148,800 | $214,272 | 0.08% |
XTX Topco Ltd | 296,601 | $427,105 | 0.07% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 234,000 | $336,960 | 0.06% |
LEVEL FOUR ADVISORY SERVICES, LLC | 183,400 | $264,096 | 0.02% |
Curi Wealth Management, LLC | 70,742 | $101,869 | 0.02% |
FRANKLIN STREET ADVISORS INC /NC | 83,400 | $120 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,000 | $201,600 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 573,256 | $825,489 | 0.01% |
ALGERT GLOBAL LLC | 68,100 | $98 | 0.01% |